Sign in / Join Now
ETFs & Funds
DelMar Pharmaceuticals: Following The Former CEO Of Celgene On His Fight Against Brain Cancer $
Add a reply...
Latest StockTalks »
people get DMPI breaking news and analysis by email alert.
Get email alerts on DMPI »
DelMar Pharmaceuticals, Inc.
Get latest price
From other sites
DelMar Pharmaceuticals Presents Overview Of VAL-083's Unique Anticancer Mechanism At The European Association Of Neuro-Oncology (EANO) Annual Meeting
at TheStreet (Oct 17, 2016)
DelMar Pharmaceuticals Announces Upcoming Scientific Conference Presentations
at TheStreet (Oct 13, 2016)
DelMar Pharmaceuticals Presents Data Supporting The Potential Of VAL-083 As A New Treatment For Ovarian Cancer At The 11th Biennial Ovarian Cancer Research Symposium
at TheStreet (Sep 13, 2016)
DelMar Pharmaceuticals And Accurexa To Collaborate In The Development Of A Novel Combination Chemotherapy For The Local Treatment Of Brain Cancer
at TheStreet (Sep 7, 2016)
DelMar Pharmaceuticals To Present At The 18th Annual Rodman & Renshaw Global Investment Conference On September 13, 2016
at TheStreet (Aug 30, 2016)